Valganciclovir 50mg/mL Oral Suspension from China
Liquid oral suspension at 50mg/mL valganciclovir hydrochloride for pediatric or swallowing-impaired patients treating CMV disease. HTS 3004.90.92.05 applies as it's a measured dose antiviral containing valganciclovir salt for retail therapeutic use.
Duty Rate — China → United States
100%
Rate breakdown
9903.04.60100%Pharmaceuticals Annex IV: patented pharma articles — 100% floor rate
9903.05.860%Universal product exemption (U.S. note 52(b))
9903.05.900%Articles already subject to Section 232 (steel/aluminum/copper + derivatives, autos + parts, wood, medium/heavy vehicles + parts, semiconductors, patented pharma) — U.S. note 52(f)
Import Tips
• Provide validated stability data for liquid formulation under varying storage conditions
• Ensure child-resistant closures meet CPSC standards for liquid medicaments
• Test for microbial contamination specific to oral suspensions during import inspection